Clinical Trials Browser

Phase 1 × NIH × tariquidar × Clear all

NCT00011414 2019-07-16

Phase I Trial of Tariquidar (XR9576) in Combination With Doxorubicin, Vinorelbine, or Docetaxel in Pediatric Patients With Solid Tumors

Phase 1 Completed

CNSGenitourinarySarcoma

Brain Neoplasms, Neoplasms, Wilms Tumor, Sarcoma

NCT00001944 2008-03-04

Vinorelbine and XR9576 to Treat Cancer

Phase 1 Completed

BreastGynecologicThoracic

Breast Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms